RB
Richmond Brothers Portfolio holdings
AUM
$153M
This Quarter Return
+12.78%
1 Year Return
+15.91%
3 Year Return
+117.95%
5 Year Return
–
10 Year Return
–
AUM
$57.4M
AUM Growth
+$57.4M
(+7.7%)
Cap. Flow
-$2.19M
Cap. Flow
% of AUM
-3.83%
Top 10 Holdings %
Top 10 Hldgs %
91.97%
Holding
25
New
1
Increased
5
Reduced
12
Closed
2
Top Buys
| 1 |
Guggenheim Strategic Opportunities Fund
GOF
|
$468K |
| 2 |
Heron Therapeutics
HRTX
|
$329K |
| 3 |
DURECT Corp
DRRX
|
$306K |
| 4 |
Amazon
AMZN
|
$7.6K |
| 5 |
Rockwell Medical
RMTI
|
$3.93K |
Top Sells
| 1 |
MiMedx Group
MDXG
|
$675K |
| 2 |
Invesco QQQ Trust
QQQ
|
$565K |
| 3 |
IRD
Opus Genetics, Inc. Common Stock
IRD
|
$347K |
| 4 |
Apple
AAPL
|
$321K |
| 5 |
iShares Biotechnology ETF
IBB
|
$317K |
Sector Composition
| 1 | Healthcare | 27.27% |
| 2 | Technology | 14.39% |
| 3 | Financials | 9.16% |
| 4 | Consumer Discretionary | 1.66% |
| 5 | Communication Services | 0.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Invesco QQQ Trust
QQQ
$364B
| $18.5M | 32.31% |
45,258
-1,380
| -3% | -$565K |
|
|
2
MiMedx Group
MDXG
$1.05B
| $12.3M | 21.47% |
1,404,352
-76,980
| -5% | -$675K |
|
|
3
Apple
AAPL
$3.45T
| $6.3M | 10.98% |
32,730
-1,665
| -5% | -$321K |
|
4
Berkshire Hathaway Class B
BRK.B
$1.09T
| $5.26M | 9.16% |
14,739
-701
| -5% | -$250K |
|
|
5
Guggenheim Strategic Opportunities Fund
GOF
$2.62B
| $3.81M | 6.63% |
297,281
+36,581
| +14% | +$468K |
|
6
Microsoft
MSFT
$3.77T
| $1.96M | 3.41% |
5,205
-42
| -0.8% | -$15.8K |
|
7
ARK Innovation ETF
ARKK
$7.45B
| $1.79M | 3.12% |
34,167
-4,373
| -11% | -$229K |
|
|
8
iShares Biotechnology ETF
IBB
$5.6B
| $1.26M | 2.2% |
9,285
-2,331
| -20% | -$317K |
|
|
9
Rockwell Medical
RMTI
$58.9M
| $780K | 1.36% |
412,433
+2,081
| +0.5% | +$3.93K |
|
|
IRD
10
Opus Genetics, Inc. Common Stock
IRD
$73.1M
| $761K | 1.33% |
252,769
-115,234
| -31% | -$347K |
|
11
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.53B
| $612K | 1.07% |
51,766
-5,570
| -10% | -$65.8K |
|
|
12
Amazon
AMZN
$2.44T
| $593K | 1.03% |
3,905
+50
| +1% | +$7.6K |
|
|
13
Heron Therapeutics
HRTX
$207M
| $504K | 0.88% |
296,706
+193,697
| +188% | +$329K |
|
14
iShares Core S&P 500 ETF
IVV
$662B
| $439K | 0.77% |
919
| – | – |
|
15
Applied Therapeutics
APLT
$71M
| $414K | 0.72% |
123,654
| – | – |
|
16
McDonald's
MCD
$224B
| $356K | 0.62% |
1,202
-85
| -7% | -$25.2K |
|
17
Air Industries Group
AIRI
$15.2M
| $318K | 0.55% |
97,953
-13,366
| -12% | -$43.4K |
|
|
18
DURECT Corp
DRRX
$59.6M
| $306K | 0.53% |
+518,294
| New | +$306K |
|
|
AXNX
19
DELISTED
Axonics, Inc. Common Stock
AXNX
| $296K | 0.52% |
4,749
| – | – |
|
20
Alphabet (Google) Class C
GOOG
$2.58T
| $281K | 0.49% |
1,995
+15
| +0.8% | +$2.11K |
|
|
ONCT
21
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $265K | 0.46% |
494,042
| – | – |
|
22
Verizon
VZ
$186B
| $217K | 0.38% |
5,767
-575
| -9% | -$21.7K |
|
|
CRGE
23
DELISTED
Charge Enterprises, Inc. Common Stock
CRGE
| $2.28K | ﹤0.01% |
20,000
| – | – |
|
24
Johnson & Johnson
JNJ
$427B
| – | – |
-1,349
| Closed | -$210K |
|
25
Procter & Gamble
PG
$368B
| – | – |
-1,549
| Closed | -$226K |
|